A recent study reveals that some colon cancer cells revert to a fetal-like state, enabling them to resist chemotherapy. This oncofetal reprogramming allows cancer cells to become more adaptable and harder to eliminate, contributing to cancer recurrence. Researchers suggest combining chemotherapy with drugs that inhibit this reprogramming to improve treatment outcomes and reduce relapse.Why some colon cancers resist treatment: Understanding oncofetal reprogramming what did scientists discover
A recent study reveals that some colon cancer cells revert to a fetal-like state, enabling them to resist chemotherapy. This oncofetal reprogramming allows cancer cells to become more adaptable and harder to eliminate, contributing to cancer recurrence. Researchers suggest combining chemotherapy with drugs that inhibit this reprogramming to improve treatment outcomes and reduce relapse.